Author Question: When referring to learning improvement, the _____ represents a reduction in the cumulative average ... (Read 74 times)

newyorker26

  • Hero Member
  • *****
  • Posts: 536
When referring to learning improvement, the _____ represents a reduction in the cumulative average number of labor hours as production doubles from a previous level.
 a. critical path
 b. slack path
 c. expected activity time
  d. learning rate
 e. early finish

Question 2

The total score arrived at in the weighted factor score approach represents:
 a. The probability of choosing a particular channel structure alternative.
  b. The probability that the channel structure alternative chosen will be optimal.
  c. A quantitative representation of management's judgment on the merits of a particular channel alternative.
  d. The optimal channel choice.
  e. The only logical channel alternative.



Melissahxx

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

d

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Green tea is able to stop the scent of garlic or onion from causing bad breath.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library